It's been a year since the first Israeli SAF conference was initiated at the Weizmann institute by me and Dr. Udi Galun, bringing together over 80 representatives from academia, government, and the market. Following the success of the event, efforts were focused on establishing a SAF consortium with the support of the Innovation Authority.
After a strategic meeting with Aviv Zeevi Balasiano, I decided to appoint Zeev Savion to lead the application process.
Thanks to the relentless efforts of Zeev, Eliko Angel, Moti Herskowitz, Sivan Perl, Gideon Lapidoth, Sobhi Basheer, and many others, the MAGNET application has successfully advanced to the final stage, securing up to an impressive 50 million NIS (~$12m) for a three-year program for R&D.
Israeli SAF development is progressing steadily, and exciting updates are on the horizon! 🛫 🌍
🎉 Exciting News! 🎉 We're officially 200 days away from the IALEIA Conference in New Orleans! 🎈 Get ready for an incredible gathering of intelligence and analysis experts. Save the date and stay tuned for updates. 🗓️📌 #IALEIAConference#CountdownToNOLA#IntelligenceExperts
Kelath Murali Manoj's response to Cyrus Khojasteh, Senior Director at Genentech, in response to his "compliment" to the assembly of "pseudo-professionals" of the ISSX meeting coming up!! (I have to call them so, because they do not consider evidence and publications that counter their line of thinking! This is not a matter of choice, it is a professional/moral obligation!!)
My Frontiers in Pharmacology (2016) paper lists 50 distinct unassailable points that ESTABLISHED why the classical approach to xenobiotic/drug metabolism is flawed and murburn model explains liver metabolism mediated by CYPs-CPR. (https://lnkd.in/gkqdyGJZ) Further, my group's published works are in mainstream journals like PLoS One, BBRC, Dose Response, and CDM. Not only that, now murburn model is established for mitochondrial redox phosphorylations too! See the latest of my talks here: https://lnkd.in/gsgXaC-4 (from 37th minute).
The findings pose profound impact on lead-drug optimization, understanding dose responses, drug-drug interactions and pharmacokinetics. I had spent thousands of dollars from my own pocket to come to USA and presented my works to you folks on CYP-CPR metabolism in GRC and ISSX conference in 2015. What good was my presentation to you folks at Genentech before this year's GRC? I had requested for attention with your organizers and didn't get it, and then made scenes with the leaders at the ISSX meeting in 2015 (Florida) so that your leadership feathers would be ruffled. It didn't. How thick-skinned are you folks?? The so-called prestigious GRC is a FARCE! I was disciplined by Mike Zientek of Pfizer (Chair) for trying to reach out (by email) to fellow researchers with my findings at the venue, when the advertisement had proclaimed that one could freely interact with attendee researchers!
Your all-star line-up is a serious joke! Your complementing each other, disregarding the murburn model of xenobiotic/drug metabolism is deplorable. I must say it is a great disservice you folks do to the public and to yourselves. You all will go down in history, with this attitude. (Including the pioneering stalwarts like Coon, Guengerich, Ortiz de Montellano, Sligar, etc.!) Keep such meetings at exotic places, go there, eat-drink and form consensus that don't make any sense to us, and just go on patting each others back when the winds of change had already blown! I have all the evidence to show for all of my claims.
It's a sham(e)!!
I hate to do this (casting aspersions on associations/institutions), but you folks (and your leaderships) leave me no options and now, I have to do this.
Connect with industry leaders, gain insights, and chart the course to financial success! Don't miss this opportunity to network, learn, and thrive. Save the date and let's navigate the future of healthcare finance together! 🏥💰 #HFMA#PrivalAnalytics#BetterInsightsBetterHealthcare#PrevailWithPrival
We are thrilled to announce several significant additions to our association:
• Welcoming our new chairman, Christian Merkt, succeeding Armin Gräter after his successful 3-year tenure of the CCAM Association.
• Introducing our new co-leader for Cluster 4 - Julian Schindler from German Aerospace Center (DLR) - and our new partnership delegates, Evangelos Bekiaris, Thorsten Möginger and Frank Niggemeier-Oliva.
• Celebrating 16 new members joining our ranks, bringing additional perspectives and energy.
These new additions mark a pivotal moment for the CCAM Association, which continues to grow and evolve and is committed to fostering an environment of collaboration.
Join us in welcoming our new chairman and members!
#CCAM#EUPartnerships#EUTransportResearch#HorizonEU#Collaboration
Dr. Glicerio M. Maningas, President of Pamantasan ng Lungsod ng Pasig, spoke about the advantage of successful partnership during the recently held CEM 45th Anniversary Virtual Conference. Here's a quote from his speech.
#CEM45#TheTestOfExcellence
Hope to see you there and reflect jointly on how to successfully implement missions (examples provided in the TRAMI playbook) and how to carry them forward in FP10!
Head of Strategy and Plans Division leading cross-domain innovations in defense.
3wYuval K. , you did great work. It’s a privilege to be part of the process.